Abstract
This exploratory, descriptive and prospective study aimed to identify the degree of adherence to psychopharmacological treatment of patients who were discharged from psychiatric hospitalization and their knowledge about their prescription and diagnosis. The study was carried out at a Mental Health Service. The sample consisted of all service clients who were discharged from psychiatric hospitalization in the data collection period. A Sociodemographic Questionnaire and the Morisky-Green Test were the instruments used. Data were analyzed through central trend measures. In total, 48 patients participated in the study. Regarding adherence, 70.8% of them showed a low adherence level to psychopharmacological treatment. Moreover, only twenty-one patients knew what their diagnosis was and most did not know or partially knew the name and dose of all prescribed medications.
Highlights
Patients’ adherence to the prescribed medication treatment is a desirable behavior for treating all chronic conditions
Among other goals, adherence aims to permit psychopharmacological treatment to be of help in psychiatric symptom control, permit better disease management and minimize the risk of relapse and the need for countless consecutive psychiatric hospitalizations[1]
This research among discharged patients permitted the identification of important aspects regarding adherence to psychopharmacological treatment, such as the prevalence of severe and persistent mental disorder diagnoses, patients’ low knowledge levels regarding their prescription and the time since diagnosis
Summary
Patients’ adherence to the prescribed medication treatment is a desirable behavior for treating all chronic conditions. Among other goals, adherence aims to permit psychopharmacological treatment to be of help in psychiatric symptom control, permit better disease management and minimize the risk of relapse and the need for countless consecutive psychiatric hospitalizations[1]. Non-adherence to medication is observed in about 50% of people and responsible for countless harm, hampering therapeutic and psychosocial approaches, interaction between health teams and patients, besides impairing patients’. Social reintegration[2,3] Recent studies involving patients diagnosed with schizophrenia suggest that the risk of relapse ranges between 3.5 and 10% per month, approximately[3,4] and indicate non adherence to psychopharmacological treatment as the main reason for relapse in non-hospitalized patients[5].
Sign-in/Register to view highlights & summary Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
